Your session is about to expire
← Back to Search
NGENUITY vs Conventional Microscope for Glaucoma
N/A
Waitlist Available
Led By Robert T Chang, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 minutes
Awards & highlights
No Placebo-Only Group
Summary
This trial is comparing the effectiveness and educational benefits of using a 3D camera system versus a traditional microscope for new surgeons placing Hydrus microstents. The 3D system aims to provide a clearer view, potentially making the procedure easier to learn and perform.
Eligible Conditions
- Glaucoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Change in attending/fellow questionnaire
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: NGENUITYExperimental Treatment1 Intervention
Research fellow participants utilize NGENUITY during micro-stent placement
Group II: Conventional microscopeActive Control1 Intervention
Research fellow participants utilize conventional microscope during micro-stent placement
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NGENUITY
2023
N/A
~30
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,471 Previous Clinical Trials
17,501,750 Total Patients Enrolled
13 Trials studying Glaucoma
625 Patients Enrolled for Glaucoma
Alcon VisionUNKNOWN
Robert T Chang, MDPrincipal InvestigatorStanford University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have mild to moderate glaucoma and cataracts, and you are scheduled for a simple cataract surgery with the Hydrus microstent.You can enroll in the study if you have vision problems in one or both eyes.You are unable to cooperate during the stent placement procedure which can affect the success of the procedure.Your cataract surgery was complicated and made it difficult to see the angle of your eye.
Research Study Groups:
This trial has the following groups:- Group 1: NGENUITY
- Group 2: Conventional microscope
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger